Education
About Us
Working with TipRanks
Follow Us
Quest Pharmatech (TSE:QPT)
:QPT
QPT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.06
Previous CloseN/A
VolumeN/A
Average Volume (3M)22.48K
Market Cap
C$9.30M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)1.00M
Price to Earnings (P/E)―
Beta-2.84
Next Earnings
Jun 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding169,129,240
10 Day Avg. Volume30,100
30 Day Avg. Volume22,481
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Quest Pharmatech News
PremiumCompany Announcements
Quest PharmaTech Strengthens Stake in Cancer Immunotherapy
PremiumCompany Announcements
Quest PharmaTech Elects Board Members and Grants Stock OptionsQPT FAQ
What was Quest Pharmatech’s price range in the past 12 months?
Quest Pharmatech lowest stock price was C$0.01 and its highest was C$0.06 in the past 12 months.
What is Quest Pharmatech’s market cap?
Quest Pharmatech’s market cap is C$9.30M.
When is Quest Pharmatech’s upcoming earnings report date?
Quest Pharmatech’s upcoming earnings report date is Jun 26, 2025 which is in 13 days.
How were Quest Pharmatech’s earnings last quarter?
Currently, no data Available
Is Quest Pharmatech overvalued?
According to Wall Street analysts Quest Pharmatech’s price is currently Overvalued.
Does Quest Pharmatech pay dividends?
Quest Pharmatech does not currently pay dividends.
What is Quest Pharmatech’s EPS estimate?
Quest Pharmatech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Quest Pharmatech have?
Quest Pharmatech has 169,129,240 shares outstanding.
What happened to Quest Pharmatech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Quest Pharmatech?
Currently, no hedge funds are holding shares in TSE:QPT
Company Description
Quest Pharmatech
Quest PharmaTech Inc is a Canadian based pharmaceutical company. The company through its subsidiary is developing antibody-based immunotherapeutic products for cancer. In addition, it owns the photodynamic therapy technology for oncology and dermatology applications.
Technical Analysis
Aptose Biosciences
―
XORTX Therapeutics Inc
―
Innovotech
―
Core One Labs
―
Glow LifeTech
―